Hi, Shrewd!        Login  
Shrewd'm.com 
A merry & shrewd investing community
Best Of ESPRBest OfAll BoardsThe Shrewd’m WeeklyLearn to InvestHow to Become Shrewd
Search
Shrewd'm.com Merry shrewd investors
Search
Best Of ESPRBest OfAll BoardsThe Shrewd’m WeeklyLearn to InvestHow to Become Shrewd


The week's question
In December 2024, in the thread "Re: BRK: Why Not XOM?", BreckHutHigh asked the members: "What about the long road trips with kids?" This week it is put to everyone again. The button below opens the small thread re-asking it - read what others have said so far, then give your own answer as an ordinary reply.
Answer this questionContinue to Shrewd'mThis note won't appear again
Stocks A to Z / Stocks E / Esperion Therapeutics (ESPR)
Unthreaded | Threaded | Whole Thread (1) |
Author: LucidDreamer   😊 😞
Number: of 19 
Subject: PR tied to their Japan partner
Date: 11/26/24 10:19 AM
Post New | Post Reply | Report Post | Recommend It!
No. of Recommendations: 3
Otsuka, the Japan partner, took the expected next step of submitting the drug so they can start selling in 2025. This is expected to trigger a $20m milestone payment to Esperion, presumably here in Q4.

While expected, it is good to see things moving forward.

esperion.com - Otsuka submits new drug application japan bempedoic acid

Dreamer
Post New | Post Reply | Report Post | Recommend It!
Print the post
Members reply directly to LucidDreamer here — and replies get answered. Reading is free; so is joining the conversation. Join Shrewd'm »
This community has written 19 posts about Esperion Therapeutics. The article-length ones it recommended most:
Anatomy of a Moon Shot... · 11 recs · 2024
Unthreaded | Threaded | Whole Thread (1) |


Announcements
Esperion Therapeutics FAQ
Contact Shrewd'm
Contact the developer of these message boards.

Best Of ESPR | Best Of | Favourites & Replies | All Boards | Followed Shrewds | Open Questions | Moving a community